Core Insights - Carvana reported a revenue of $5.6 billion for the quarter ended December 2025, marking a 58% increase year-over-year, with an EPS of $4.22 compared to $0.56 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $5.22 billion by 7.32%, and the EPS surpassed the consensus estimate of $1.13 by 274.35% [1] Financial Performance Metrics - Retail vehicle unit sales reached 163,522, slightly above the average estimate of 158,132 [4] - Per retail unit gross profit for total sales was $6,427, lower than the average estimate of $6,781.18 [4] - Per retail unit gross profit for retail vehicles was $2,990, compared to the estimated $3,198.55 [4] - Sales and operating revenues from retail vehicle sales were $4.16 billion, exceeding the average estimate of $3.82 billion, reflecting a year-over-year increase of 62.9% [4] - Wholesale sales and revenues amounted to $988 million, surpassing the average estimate of $950.96 million, with a year-over-year change of 45.7% [4] Market Performance - Carvana's shares have declined by 20.7% over the past month, while the Zacks S&P 500 composite decreased by 1.3% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Group 1: Somnigroup International Performance - For the quarter ended December 2025, Somnigroup International reported revenue of $1.87 billion, reflecting a year-over-year increase of 54.7% [1] - The earnings per share (EPS) for the quarter was $0.72, up from $0.60 in the same quarter last year, indicating a positive growth trend [1] - The reported revenue was a surprise of -3.24% compared to the Zacks Consensus Estimate of $1.93 billion, while the EPS surprise was +0.56% against the consensus estimate [1] Group 2: Market Comparison and Stock Performance - Somnigroup International's shares have returned +2.2% over the past month, contrasting with the Zacks S&P 500 composite's -1.4% change, suggesting relative strength in the stock [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating it may perform in line with the broader market in the near term [3] Group 3: Tempur Sealy Financial Metrics - Tempur Sealy North America's net sales were reported at $620.5 million, which is a -30.6% change year-over-year and below the average estimate of $650.53 million [4] - Tempur Sealy International's net sales reached $355.8 million, representing a +13.4% change year-over-year and exceeding the average estimate of $338.86 million [4] - Direct sales for Tempur Sealy International were $224.6 million, showing a +14.9% year-over-year change and surpassing the average estimate of $215.72 million [4]

Core Insights - Privia Health reported revenue of $521.15 million for the quarter ended June 2025, reflecting a year-over-year increase of 23.4% and a positive surprise of 11.24% over the Zacks Consensus Estimate of $468.49 million [1] - The company's EPS was $0.02, down from $0.03 in the same quarter last year, resulting in a negative surprise of 60% compared to the consensus estimate of $0.05 [1] Financial Performance Metrics - Practice Collections reached $862.9 million, exceeding the five-analyst average estimate of $804.11 million [4] - Care Margin was reported at $115.2 million, also above the five-analyst average estimate of $109.25 million [4] - Platform Contribution amounted to $57.5 million, surpassing the average estimate of $52.25 million from five analysts [4] - The number of Implemented Providers at the end of the period was 5,125, exceeding the average estimate of 4,967 from two analysts [4] - Value-Based Care Attributed Lives stood at 1.38 million, above the two-analyst average estimate of 1.3 million [4] Stock Performance - Over the past month, Privia Health's shares have returned -6.7%, contrasting with the Zacks S&P 500 composite's increase of +1.2% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Financial Performance - For the quarter ended March 2025, USA Compression Partners (USAC) reported revenue of $245.23 million, which is a 7% increase compared to the same period last year [1] - The earnings per share (EPS) for the quarter was $0.18, up from $0.16 in the year-ago quarter [1] - The reported revenue exceeded the Zacks Consensus Estimate of $244.02 million, resulting in a surprise of +0.50% [1] - The company experienced an EPS surprise of -18.18%, with the consensus EPS estimate being $0.22 [1] Key Metrics - Revenue-generating horsepower at period end was 3.56 billion, matching the two-analyst average estimate [4] - Average revenue-generating horsepower was also 3.56 billion, slightly below the two-analyst average estimate of 3.6 billion [4] - Revenues from parts and service were reported at $5.09 million, which is lower than the estimated $6.22 million, representing a -6.7% change year over year [4] - Revenues from contract operations were $224.98 million, compared to the average estimate of $237.63 million, reflecting a +3.2% year-over-year change [4] Stock Performance - Shares of USA Compression have returned +4.7% over the past month, while the Zacks S&P 500 composite has changed by +10.6% [3] - The stock currently holds a Zacks Rank 5 (Strong Sell), indicating potential underperformance relative to the broader market in the near term [3]